1 / 18

Pandemic Influenza: History & Epidemiology

Pandemic Influenza: History & Epidemiology. Kathryn H. Jacobsen, MPH, PhD Dept. of Global & Community Health George Mason University. What is “normal” flu?. Respiratory disease Symptoms: fever, muscle aches, cough, sore throat, runny nose, and possible nausea May develop into pneumonia

schuyler
Download Presentation

Pandemic Influenza: History & Epidemiology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pandemic Influenza: History & Epidemiology Kathryn H. Jacobsen, MPH, PhD Dept. of Global & Community Health George Mason University

  2. What is “normal” flu? • Respiratory disease • Symptoms: fever, muscle aches, cough, sore throat, runny nose, and possible nausea • May develop into pneumonia • Spread by airborne droplets that reach the eyes, nose, or mouth; may also be spread by touching contaminated surfaces and then the face • The elderly, very young, and those with weakened immune systems are at risk of severe illness (especially pneumonia) and death. • 30,000 – 40,000 deaths in the USA in a “normal” flu year (and 5 – 20% of the population sick)

  3. Why are we susceptible to new flu strains?: Antigenic Drift • Influenza viruses frequently mutate (antigenic drift). • Surface proteins change in ways that make it difficult for our immune systems to quickly identify them and fight them off. • A new flu vaccine is developed every year to adjust for the changes in the circulating flu viruses.

  4. Why are we susceptible to new flu strains?: Antigenic Shift • Two very different types of flu virus that infect one animal can merge to create a completely new strain (antigenic shift). • Most common strain in humans in recent decades: H3N2 • “Bird flu”: H5N1 Domestic birds Domestic pigs Humans

  5. What is “bird flu”? • Many flu strains are “bird flu” or “pig flu”, etc. • Avian influenza H5N1 is a flu virus type that primarily affects birds; highly contagious in birds and has resulted in many bird deaths • Bird flu is “species specific” and rarely infects humans; only a few hundred humans are known to have contracted H5N1 • Genetic changes may cause H5N1 to develop the ability to more easily infect humans Domestic birds Domestic pigs Humans Wild birds

  6. Why are we concerned about H5N1? • Most humans have no immunity to H5N1 • About half of the humans known to have been infected with H5N1 have died. • Important note: This is an overestimation of the true case fatality rate because only severe cases are tested. • All had direct and prolonged contact with poultry or bird habitats. • Most cases have occurred in children and young adults.

  7. Why are we concerned about a possible pandemic? • Conditions for a pandemic • (1) Emergence of a new flu strain • (2) Ability of the strain to infect humans and cause severe illness • (3) Ability to spread easily among humans • If further mutations of the H5N1 virus occur and the virus becomes easy to transmit from human to human a global outbreak (pandemic) could occur.

  8. WHO Pandemic Staging • Interpandemic Period • Phase 1 – Low Risk: No new influenza virus subtypes in humans • Phase 2 – New Virus: No new flu in humans but an animal variant emerges • Pandemic Alert Period • Phase 3 – Self Limiting: Human infections but no human-to-human transmission • Phase 4 – Person-to-Person: Small clusters with limited human-to-human transmission • Phase 5 - Epidemic: Larger but still localized clusters • Pandemic Period • Phase 6 - Pandemic: Increased and sustained transmission in the general population

  9. Pandemics (Global Epidemics) in History • 541 CE, bubonic plague spreads from Egypt to Constantinople then beyond, killing up to ¼ of the population of the eastern Mediterranean • 1300s CE, bubonic plague (“Black Death”) returns to Europe from Asia and kills up to ¼ of the population (and more than half in the hardest hit areas) • 1500s CE, typhus pandemics; Europeans bring smallpox and other epidemic infections to the Americas • A series of cholera outbreaks in the 1800s hit all continents

  10. Pandemic Influenza History • 1580: Africa  Europe • 1729: Russia  Europe • 1781-1782: China  Russia  Europe • 1830-1833: China  Pacific and India  Russia  Europe • 1889-1900 “Asiatic flu”: Russia  Mediterranean  North America  South America  India and Australia • 1918-1919 “Spanish flu”: Started in October 1918, quickly spread worldwide, and vanished within 18 months • 1957-1958 “Asian flu” • 1968-1969 “Hong Kong flu” Potter CW, A history of influenza, Journal of Applied Microbiology 2001; 91: 572-579.

  11. Why are we concerned about a possible pandemic? • Modern influenza pandemics tend to occur every 20 to 30 years ?

  12. Where is H5N1 now? Nations With Confirmed Cases H5N1 Avian Influenza (July 7, 2006) http://www.pandemicflu.gov/

  13. How quickly will it spread? • It may take several weeks for an initial outbreak to be announced • Influenza may be found in dozens of countries within a week or a few weeks • Travel advisories and warnings may be issued quickly and restrict international travel and/or local travel • Quarantine orders may be issued within weeks • Thousands to millions may become infected

  14. Sample Timelines

  15. Sample Timelines

  16. How can we respond to H5N1? • A flu vaccine might be developed – but probably not in time to prevent a pandemic because human-to-human transmissible H5N1 does not yet exist. • Production capacity may also be an issue. • Antiviral drugs that mitigate symptoms (like Tamiflu and Relenza) may not work against this strain. • We do know that normal preventive measures will be helpful in preventing transmission. • We can plan!

  17. Areas of Concern Addressed during Today’s Conference • Clinical features of H5N1 • Comparisons to other EIDs like SARS • Planning, security, communications, and preparation

More Related